Cargando…
The Evolution of Insulin and How it Informs Therapy and Treatment Choices
Insulin has been available for the treatment of diabetes for almost a century, and the variety of insulin choices today represents many years of discovery and innovation. Insulin has gone from poorly defined extracts of animal pancreata to pure and precisely controlled formulations that can be presc...
Autores principales: | Hirsch, Irl B, Juneja, Rattan, Beals, John M, Antalis, Caryl J, Wright, Eugene E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366348/ https://www.ncbi.nlm.nih.gov/pubmed/32396624 http://dx.doi.org/10.1210/endrev/bnaa015 |
Ejemplares similares
-
Insulin in America: A Right or a Privilege?
por: Hirsch, Irl B.
Publicado: (2016) -
Using Flash Continuous Glucose Monitoring in Primary Practice
por: Hirsch, Irl B., et al.
Publicado: (2019) -
Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125–1131
por: Beran, David, et al.
Publicado: (2018) -
The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
por: Orchard, Trevor J., et al.
Publicado: (2017) -
Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis
por: Singh, Sonal, et al.
Publicado: (2016)